K2 Medical Research

Clermont, Florida 34711

0 studies enrolling now · 5 studies all time

What they study most

Alzheimer Disease, Alzheimer's Disease, Brain Diseases, Central Nervous System Diseases, Dementia, Early Alzheimers Disease, Mental Disorders, Nervous System Diseases, Neurocognitive Disorders, Neurodegenerative Diseases

Studies at this site

• A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6) — Running, not enrolling
• A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD — Running, not enrolling
• A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease — Running, not enrolling
• Study of ASN51 in Adults With Early Alzheimer's Disease — Stopped early
• A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD — Completed